Shenzhen YHLO BIOTECH Co., Ltd: YHLO is a leading company of immunoassay solutions in China. Founded in 2008 and headquartered in Shenzhen China, YHLO is specialized in developing, manufacturing and distributing in-vitro diagnostic reagents and instruments for diagnosis of autoimmune diseases, reproductive health, infectious diseases and so on.
Show more
See More
New corner stone laid, the second biopark of YHLO began construction. YHLO (EST. 2008) is an innovative and steadfastly growing company of immunoassay solutions headquartered in Shenzhen, China, specialized in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents by a team of experienced scientists and engineers. In May of 2021, YHLO has successfully …
Show more
See More
Add: Building 1, YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict, Longgang District, Shenzhen, P.R.China Operation Guide For GLINE-2019-nCoV Ag Self Test Jun 01, 2021
Show more
See More
Shenzhen YHLO BIOTECH Co., Ltd Rm.501, Building A1, Kexing Science Park No.15 Keyuan Road, Nanshan District , 518057 Shenzhen China Telephone +86 755 26601910 (ext.8128)
Show more
See More
Shenzhen YHLO BIOTECH Co Ltd Original Assignee Shenzhen YHLO BIOTECH Co Ltd Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) 2011-01-12 Filing date 2011-01-12 Publication date 2011-08-10
Show more
See More
Company profile page for Shenzhen YHLO BIOTECH Co Ltd including stock price, company news, press releases, executives, board members, and contact information
Show more
See More
YHLO. 659 likes · 7 talking about this. Medical & Health
Show more
See More
Dec 02, 2016 . Shenzhen YHLO BIOTECH Co., Ltd. (YHLO) is the leading company of Autoimmunity Solutions in China. Founded in 2008 and headquartered in Shenzhen China, together with a R&D center in Europe, YHLO is specialized in developing, manufacturing and distributing In-Vitro Diagnostic instruments and reagents by a team of high-skilled scientists and engineers.
Show more
See More
The Shenzhen YHLO BIOTECH IgM and IgG assay targeting other surface patterns was used as a confirmatory test. Results The Roche assay demonstrated a limit of detection of 0.069 cutoff index and successfully passed the performance validation according to Clinical and Laboratory Standards Institute EP15-A3.
Show more
See More
Advanced Diagnostics Co., Ltd. Nov 2006 - Present14 years 9 months. Yangon, MYANMAR. Distributor for IVD Medical Devices, Molecular Diagnostics, POCT, Scientific Analytical Instruments, Clinical and Industrial Laboratory Accessories, Analytical Grades Chemicals and consumables.
Show more
See More
Results for chemo-luminescent detection of anti-S1 spike protein antibodies (YHLO BIOTECH) and anti-nucleocapsid antibodies (Immunodiagnostik) were compared between S1 …
Show more
See More
3 Shenzhen YHLO BIOTECH Co., ... to guide healthy food and proper exercise for pregnant women. ... layers involved (D). This device is practical in terms of its reproducibility, as well as its flexible and disposable design for easy application, high sensitivity of 82 μA mM −1 cm −2 and high selectivity, and finally its ability to use very ...
Show more
See More
Shenzhen YHLO BIOTECH, chemiluminescence assay: Viral serological testing is an effective means of diagnosing SARS-CoV-2 infection. The positive rate and titre variance of IgG are higher than those of IgM: 48.1 IgM 88.9 IgG: 100 IgM 90.9 IgG: NA: NA Pan Y et al., 2020: Retrospective: 105: 105 patients: China: In-house assay: Immunochromatography
Show more
See More
The experimental design and data of 7 studies were judged to provide insight into LFIA method applications. ... Shenzhen YHLO BIOTECH ... and some reports proposed that monitoring titers may be applied in clinical practice to guide earlier aggressive treatment. Traditionally, the hallmarks of a humoral immune response include the early ...
Show more
See More
Jun 01, 2018 . 2845 Shenzhen YHLO BIOTECH Co., Ltd. 4478 Shimadzu Scientific Instruments, Inc. 4678 Shin Jin Medics Inc. 1786 Shinhan FA System. 2812 Siemens Healthineers. 4636 Sinnowa Medical Science & Technology Co., Ltd. 1059 SiO2 Medical Products. 4456 SJK Global LLC. 3980 SLR Research Corporation. 3579 SMC Biosolutions. 836 SMC Corporation of America
Show more
See More
YHLO (EST. 2008) is an innovative and steadfastly growing company of immunoassay solutions headquartered in Shenzhen, China, specialized in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents by a team of experienced scientists and engineers.
Recently, Zhongnan Hospital of Wuhan University used YHLO reagents to further analyze the protective immunity of SARS-CoV-2, which provided a basis for understanding the pathogenesis of COVID-19 and provided assistance for the development of effective SARS-CoV-2 vaccine. The research has now...
As a national high-tech enterprise with many intellectual properties, YHLO’s mission is to focus on healthcare, better life with technology.
Founded in 2008 and headquartered in Shenzhen China, together with a R&D center in Europe, YHLO is specialized in developing, manufacturing and distributing In-Vitro Diagnostic instruments and reagents by a team of high-skilled scientists and engineers.
YHLO (EST. 2008) is an innovative and steadfastly growing company of immunoassay solutions headquartered in Shenzhen, China, specialized in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents by a team of experienced scientists and engineers.
Recently, Zhongnan Hospital of Wuhan University used YHLO reagents to further analyze the protective immunity of SARS-CoV-2, which provided a basis for understanding the pathogenesis of COVID-19 and provided assistance for the development of effective SARS-CoV-2 vaccine. The research has now...
As a national high-tech enterprise with many intellectual properties, YHLO’s mission is to focus on healthcare, better life with technology.